Physician profile
Stephanie M Persondek
NPI 1518288745
$137,742.22
in general payments reported to CMS, 2019-2025
15 companies · $77K in 2025
The $77K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $89.31 · 2021: $173 · 2022: $53.10 · 2023: $135 · 2024: $61K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $101K · Travel and Lodging: $23K · Consulting Fee: $7,000 · Food and Beverage: $5,826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $101,150.00 |
| Travel and Lodging | $23,237.93 |
| Consulting Fee | $7,000.00 |
| Food and Beverage | $5,825.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $133,856.93 | 2023-2025 | Zepbound, Mounjaro, Taltz |
| Abbott Laboratories | $2,800.00 | 2024 | Alinity |
| Novo Nordisk INC | $460.94 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $265.60 | 2019-2022 | |
| Hologic Sales and Service, LLC | $125.70 | 2020-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Therapeuticsmd, INC. | $34.33 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.14 | 2021 | |
| Amag Pharmaceuticals, INC. | $33.01 | 2019-2020 | |
| Organon LLC | $27.20 | 2021 | |
| Smith+Nephew, INC. | $25.47 | 2021 | |
| Daiichi Sankyo INC. | $18.10 | 2019 | |
| Olympus America INC. | $17.57 | 2022 | |
| Allergan, INC. | $17.53 | 2020 | |
| Merck Sharp & Dohme LLC | $14.67 | 2020 | |
| Coopersurgical, INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Persondek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.